ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
11 Jan 2023

Acarix genomför riktad nyemission av aktier till garanter i samband med den genomförda företrädesemissionen

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
11 Jan 2023

Acarix carries out a directed issue of shares to guarantors in connection with the completed rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Jan 2023

Acarix announces final outcome of rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
03 Jan 2023

Acarix offentliggör slutligt utfall i företrädesemission

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Dec 2022

Acarix publish supplement to prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
22 Dec 2022

Acarix offentliggör tilläggsprospekt

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
21 Dec 2022

The guarantee consortium is expanded to cover approximately 62% of the ongoing rights issue in Acarix

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
21 Dec 2022

Garantikonsortiet utökas till att omfatta cirka 62 procent av Acarix pågående företrädesemission

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Dec 2022

Acarix publishes prospectus in connection with the company’s rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, WITHIN OR TO THE UNITED STATES, AUSTRALIA, CANADA, HONG KONG, JAP...
Continue reading
author-avatar acarix
Press
August 6, 2024
14 Dec 2022

Acarix offentliggör prospekt i samband med bolagets företrädesemission

DETTA PRESSMEDDELANDE ÄR EJ FÖR OFFENTLIGGÖRANDE, DISTRIBUTION ELLER PUBLICERING, VARKEN DIREKT ELLER INDIREKT, INOM ELLER TILL USA, AU...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Dec 2021

Acarix carries out a directed issue of shares to guarantors in conjunction with completed rights issue

Press release Malmö, December 29, 2021 Acarix carries out a directed issue of shares to guarantors in conjunction with completed right...
Continue reading
author-avatar acarix
Press
August 6, 2024
29 Dec 2021

Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemission

Press release Malmö, 29 december, 2021 Acarix genomför riktad nyemission av aktier till garanter i samband med avslutad företrädesemi...
Continue reading
  • ‹
  • 1
  • 2
  • 3
  • 4
  • 5
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
info@acarix.com

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • News
  • Press
  • Events
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Full Disclaimer
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
      • What is Coronary Artery Disease
      • Diagnosing CAD
    • About the product
      • The Cadscor System
      • How Does it Work
  • Resources
    • Testimonial
      • HCP Stories
      • Patients Stories
    • References
      • Clinical Studies
      • Downloads (US)
      • Downloads (EU)
    • Support
      • Training
      • Faq
      • Reimbursement
    • Physician Locator
      • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
      • About Acarix
      • Leadership
      • Join The Team
    • Get in touch
      • Contact Us
      • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.